Bayview Pharmacy is pleased to present a specially compounded vaginal gel that contains Estradiol 0.01%, Dehydroepiandrosterone 0.5%, and Testosterone 0.05%. This unique formulation is specifically designed to address a range of menopausal conditions, including Vulvovaginal Atrophy, Dyspareunia, Postmenopausal Vaginal Dryness, Genitourinary Syndrome of Menopause, and Lichen Sclerosus.

The gel is a semisolid formulation dispensed in a tube, designed for easy and controlled application in the vaginal area. It delivers medication while providing lubrication and therapeutic effects for various gynecological purposes. The gel's consistency ensures that the active ingredients are delivered effectively and efficiently, providing maximum relief from symptoms.

Estradiol, a form of estrogen, is included in the formulation to alleviate menopausal symptoms such as vaginal dryness and thinning of the vaginal walls. Dehydroepiandrosterone, a hormone, is added to reduce inflammation and improve sexual function. Testosterone is incorporated to enhance libido and sexual satisfaction.

This comprehensive formulation aims to provide relief from a variety of menopausal symptoms, including vaginal dryness, itching, burning, and pain during intercourse. It also works to reduce inflammation and improve sexual function, enhancing overall quality of life during menopause.

If you have any questions about this formulation or how it can help manage your condition, please do not hesitate to contact us. Our team of compounding pharmacists is ready and willing to assist you with any queries you may have. We are committed to providing you with the best possible care and treatment options.

Estradiol 0.01%/Dehydroepiandrosterone 0.5%/Testosterone 0.05% Vaginal Gel is a specially formulated treatment designed for the management of various gynecological conditions. This includes vulvovaginal atrophy, dyspareunia, postmenopausal vaginal dryness, genitourinary syndrome of menopause, and lichen sclerosus. The gel is dispensed in a tube for easy and controlled application in the vaginal area.

The formulation contains three key active ingredients: Estradiol, Dehydroepiandrosterone, and Testosterone. Estradiol, a potent estrogen, works to restore the vaginal epithelium and alleviate symptoms such as vaginal dryness, itching, and burning. Dehydroepiandrosterone and Testosterone, both weak androgens, contribute to the improvement of dyspareunia and vaginal dryness symptoms.

The combination of these three hormones in the gel formulation provides a comprehensive approach to managing the symptoms of vulvovaginal atrophy, dyspareunia, postmenopausal vaginal dryness, genitourinary syndrome of menopause, and lichen sclerosus. It is crucial to understand that this product is specifically indicated for these conditions and not for the treatment of any other medical condition.

If you have any questions or require further information about this product, please do not hesitate to reach out. It is always recommended to consult with a healthcare professional before starting any new medication regimen.

This compounded formulation is a unique blend of estradiol 0.01%, dehydroepiandrosterone 0.5%, and testosterone 0.05% in a gel-like semisolid form, specifically designed for vaginal application. It is dispensed in a tube for easy and controlled application, ensuring the precise delivery of medication to the affected area. This formulation is primarily used for the treatment of various gynecological conditions such as vulvovaginal atrophy, dyspareunia, postmenopausal vaginal dryness, genitourinary syndrome of menopause, and lichen sclerosus.

The estradiol component of this formulation works to restore the vaginal epithelium, reduce inflammation, and improve lubrication. The dehydroepiandrosterone aids in alleviating symptoms of vulvovaginal atrophy, such as dryness, itching, and burning. The testosterone component is instrumental in enhancing libido and sexual function.

For optimal results, this formulation should be applied directly to the affected area once daily. It is crucial to use the correct amount of gel to avoid potential irritation. Care should be taken to avoid contact with the eyes, mouth, and other mucous membranes. The duration of use should be as short as possible to achieve the desired therapeutic effects.

It is important to note that this formulation is not recommended for use in pregnant or breastfeeding women. Additionally, women with a history of breast cancer or other hormone-sensitive conditions should refrain from using this product. Always consult with a healthcare professional before starting any new medication regimen.

This compounded formulation of Estradiol 0.01%/Dehydroepiandrosterone 0.5%/Testosterone 0.05% Vaginal Gel is a specialized treatment option designed for a variety of gynecological conditions. It has been effectively used in the management of Vulvovaginal Atrophy, Hypoactive Sexual Desire Disorder, Postmenopausal Symptoms, Dyspareunia, and Genitourinary Syndrome of Menopause. Beyond these conditions, it may also be beneficial in addressing symptoms such as vaginal dryness, itching, and burning, which can significantly impact a woman's quality of life.

Furthermore, this formulation has been found to enhance sexual satisfaction and libido in postmenopausal women, contributing to an overall improvement in their quality of life. It also has potential benefits in reducing the risk of urinary tract infections, a common concern in postmenopausal women. Additionally, it may contribute to the prevention of osteoporosis, a condition that postmenopausal women are at increased risk for due to hormonal changes.

While this formulation has a wide range of applications, it is important to consult with a healthcare provider to determine if it is the right treatment option for your specific needs. If you have any questions or concerns about this formulation, please do not hesitate to reach out for further information.